Find clinical trials for Non-Hodgkin Lymphoma in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma

B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma

Leukemia

Lymphoid Leukemia

B-Cell Chronic Lymphocytic Leukemia

Follicular Lymphoma

Non-Hodgkin Lymphoma trials near Indianapolis, IN, USA:

Study of IMPT-314 in R/R Aggressive B-cell NHL

This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of IMPT-314, a bispecific chimeric antigen receptor (CAR) targ...

Enrolling

Relapsed Non-Hodgkin Lymphoma

Refractory Non-Hodgkin Lymphoma

Drug: IMPT-314

Phase 1, Phase 2

Lyell Immunopharma

Indianapolis, Indiana, United States of America and 14 other locations

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

B-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections. The purpose of this stud...

Enrolling

Non-Hodgkin's Lymphoma

Diffuse Large B-Cell Lymphoma

Drug: ABBV-525

Phase 1

AbbVie

Indianapolis, Indiana, United States and 31 other locations

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

20-expressing Non-Hodgkin lymphoma....

Enrolling

Primary Mediastinal Large B Cell Lymphoma

Marginal Zone Lymphoma

Drug: Fludarabine

Drug: Cyclophosphamide

Phase 1

Acepodia Biotech

Indianapolis, Indiana, United States and 6 other locations

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic-...

Active, not recruiting

Classic Follicular Lymphoma

Diffuse Large B-Cell Lymphoma

Drug: Epcoritamab

Phase 2

Genmab

Indianapolis, Indiana, United States and 71 other locations

Locations recently updated

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma (OLYMPIA-2)

is focused on participants with previously untreated follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin...

Enrolling

Follicular Lymphoma (FL)

Drug: Odronextamab

Drug: Vincristine

Phase 3

Regeneron Pharmaceuticals

Noblesville, Indiana, United States and 94 other locations

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

The purpose of this study is to find out whether the study drug, LOXO-338, is safe and effective in patients with advanced blood cancer. Patients mus...

Active, not recruiting

Lymphoma, B-cell Marginal Zone

Lymphoma, Mantle-Cell

Drug: LOXO-338

Drug: Pirtobrutinib

Phase 1

Lilly

Indianapolis, Indiana, United States and 22 other locations

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma (OLYMPIA-3)

The study is focused on patients with diffuse large B-cell lymphoma (DLBCL) that have not been treated before (called "previously untreated"...

Enrolling

Diffuse Large B-cell Lymphoma (DLBCL)

Drug: Doxorubicin

Drug: Prednisone/Prednisolone

Phase 3

Regeneron Pharmaceuticals

Indianapolis, Indiana, United States and 147 other locations

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma (OLYMPIA-1)

is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL)....

Enrolling

Follicular Lymphoma (FL)

Drug: Odronextamab

Drug: Rituximab

Phase 3

Regeneron Pharmaceuticals

Noblesville, Indiana, United States and 150 other locations

A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)

Non-Hodgkin 's lymphoma (NHL).This study will be made up of two parts (Part 1 not randomized, Part 2 randomized - control...

Enrolling

Marginal Zone Lymphoma (MZL)

Relapsed/Refractory Follicular Lymphoma

Drug: Rituximab

Drug: Lenalidomide

Phase 3

Regeneron Pharmaceuticals

Indianapolis, Indiana, United States and 131 other locations

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harb...

Enrolling

Lymphoma, Non-Hodgkin

Multiple Myeloma

Drug: Trastuzumab and Pertuzumab

Drug: Palbociclib

Phase 2

American Society of Clinical Oncology

Indianapolis, Indiana, United States and 155 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Non-Hodgkin Lymphoma in .css-epvm6{white-space:nowrap;}Indianapolis, IN

Related conditions:

Non-Hodgkin Lymphoma trials near Indianapolis, IN, USA:

Study of IMPT-314 in R/R Aggressive B-cell NHL

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma (OLYMPIA-2)

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma (OLYMPIA-3)

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma (OLYMPIA-1)

A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Find clinical trials for Non-Hodgkin Lymphoma in Indianapolis, IN